European journal of haematology

The most recent articles from: Eur. J. Haematol. February 2021

Eur. J. Haematol. · Feb 2021

Multicenter Study

Daratumumab for relapsed AL amyloidosis-When cumulative real-world data precedes clinical trials: A multisite study and systematic literature review.

Patients with relapsed/refractory AL amyloidosis (RRAL) have poor prognosis, but emerging data shows promising results with the use daratumumab. We evaluated daratumumab treatment in RRAL in real-world setting. ⋯ Our data support favorable safety tolerability and efficacy of daratumumab among non-selective RRAL patients in a real-world setting.

explore further… or just mark as read…

Want more great medical articles?

Keep up to date with a free trial of metajournal, personalized for your practice.
1,694,794 articles already indexed!